DRKS00029132
Completed
未知
Physiotherapy for children and teenagers with chemotherapy induced polyneuropathy - A feasibility study
privat0 sites1 target enrollmentJune 7, 2022
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- G62.0
- Sponsor
- privat
- Enrollment
- 1
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Study design: randomized controlled trails, meta\-analysis, clinical trails, reviews and systematic reviews
- •2\. Publication period: 2000 to 2022
- •3\. Publication languages: German and English
- •4\. Subjects: Child: birth\- 18 years
Exclusion Criteria
- •1\. Intervention: drug and electrotherapeutic measures
- •2\. Quality: lack of methodological quality
- •3\. publication: non\-scientific articles
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Personalised physiotherapy treatment for young people experiencing paiMusculoskeletal painMusculoskeletal DiseasesISRCTN18918987niversity of Southampton45
Not yet recruiting
Phase 2
The osteopathic treatment of children and adolescents diagnosed with attention deficit hyperactivity disorder with and without hyperactivity (ADHD/ADS)F90Hyperkinetic disordersDRKS00029935Osteopathie Schule DeutschlandDresden International University / TU-Dresden30
Completed
Not Applicable
Physiotherapeutic Intervention in Children With Chronic Functional ConstipationChronic ConstipationNCT00906971Universidade Federal de Pernambuco72
Completed
Not Applicable
Study of how effectively physiotherapy works on correction of stiff spinal curves(scoliosis) in persons aging between 12 to 40 years(adolescents and adults.CTRI/2019/04/018501aveen Kumar Balne25
Active, not recruiting
Phase 1
Analgesia and physiotherapy in children with cerebral palsy (ANTALKINECP)Cerebral PalsyMedDRA version: 18.1 Level: PT Classification code 10008129 Term: Cerebral palsy System Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Not possible to specifyEUCTR2015-005538-23-FRCHRU de Brest180